뇌혈전 제거 디바이스 시장 점유율, 규모, 동향, 산업 분석 리포트 : 제품별, 최종 용도별, 지역별, 부문별 예측(2023-2032년)

The global neurothrombectomy devices market size is expected to reach USD 1,465.2 million by 2032, according to a new study by Polaris market research. The report "Neurothrombectomy Devices Market Share, Size, Trends, Industry Analysis Report, By Product (Clot Retrievers, Aspiration/Suction Devices, Vascular Snares); By End-Use; By Region; Segment Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The market's growth is due to the increasing incidence of acute ischemic strokes fueled by faulty lifestyles, a rise in smokers and drinkers, and a growing elderly population. Neurothrombectomy devices are crucial in retrieving blood clots from cerebral neurovascular blood vessels, improving patient outcomes, and reducing mortality rates. These devices are considered a preferred treatment option for heart strokes.

Acute ischemic stroke is a severe and prevalent form of stroke, particularly among older people, and occurs more frequently in women than men. In the UK, for instance, it is estimated that over 100,000 strokes occur each year, with approximately 1 in 10 individuals experiencing hemorrhage dying prematurely, according to the UK Stroke Association's estimates.

In addition, various government initiatives have been implemented to raise awareness and prevent heart strokes. One notable example is the WISEWOMAN program initiated by the U.S.-based Centers for Disease Control and Prevention (CDC). This program aims to reduce the risk of stroke and promote healthy lifestyles, specifically targeting uninsured women from low-income populations. Such initiatives are vital in increasing awareness about the detrimental effects of strokes within the market, leading to improved prevention and management strategies.

The market is witnessing significant trends that are driving its growth and evolution. There is a special focus on technological advancements, with the development of advanced devices such as stent retrievers, aspiration devices, and robotic-assisted systems. These innovations are enhancing the efficacy and precision of neurothrombectomy procedures. Additionally, a growing preference for minimally invasive approaches leads to increased demand for devices that enable such procedures. Minimally invasive techniques offer benefits like reduced trauma, shorter hospital stays, and improved patient outcomes.

The emphasis on clinical evidence and research is increasingly placed on gathering robust clinical data to validate these devices' safety, efficacy, and cost-effectiveness. Clinical trials and post-market registries are being conducted to generate real-world evidence and support the adoption of neurothrombectomy devices.

Moreover, collaborations and partnerships between medical device manufacturers and research institutions are facilitating the development of innovative devices and expanding product portfolios. These trends collectively reflect the dynamic nature of the neurothrombectomy devices market and highlight the ongoing efforts to improve stroke treatment outcomes through technological advancements, evidence-based practices, and collaborative initiatives.

Neurothrombectomy Devices Market Report Highlights

Clot retriever segment holds the largest revenue share in the market due to its effectiveness in removing blood clots from cerebral arteries and the growing prevalence of ischemic heart diseases alongside product innovations.

Hospital segment holds the largest revenue shares of the market and will continue its growth over the forecast period. Due to patient preference for advanced medical infrastructure and skilled surgeons, they ensure comprehensive care.

Europe accounted for the significant shares of the market. The region's growth is based on advanced healthcare infrastructure, high stroke incidence, technological innovations, favorable reimbursement coverage, and key market players

The global key market players include: Medtronic, Stryker Corporation, Acandis GmbH, Stryker Corporation, Phenox GmbH, Penumbra Inc., and Vesalio.

Polaris market research has segmented the neurothrombectomy devices market report based on product, end-use, and region:

Neurothrombectomy Devices, Product Outlook (Revenue - USD Million, 2019 - 2032)

• Clot Retrievers
• Aspiration/Suction Devices
• Vascular Snares

Neurothrombectomy Devices, End-Use Outlook (Revenue - USD Million, 2019 - 2032)

• Hospitals
• Emergency Clinics
• Ambulatory Surgical Centers

Neurothrombectomy Devices, Regional Outlook (Revenue - USD Million, 2019 - 2032)

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• France
• Italy
• Spain
• Russia
• Netherlands
• Asia Pacific
• China
• India
• Japan
• South Korea
• Indonesia
• Malaysia
• Latin America
• Argentina
• Brazil
• Mexico
• Middle East & Africa
• UAE
• Saudi Arabia
• Israel
• South Africa

Table of Contents

1. Introduction

• 1.1. Report Description
  • 1.1.1. Objectives of the Study
  • 1.1.2. Market Scope
  • 1.1.3. Assumptions
• 1.2. Stakeholders

2. Executive Summary

• 2.1. Market Highlights

3. Research Methodology

• 3.1. Overview
  • 3.1.1. Data Mining
• 3.2. Data Sources
  • 3.2.1. Primary Sources
  • 3.2.2. Secondary Sources

4. Global Neurothrombectomy Devices Market Insights

• 4.1. Neurothrombectomy Devices Market - Industry Snapshot
• 4.2. Neurothrombectomy Devices Market Dynamics
  • 4.2.1. Drivers and Opportunities
    • 4.2.1.1. Increasing incidence of stroke worldwide
    • 4.2.1.2. Advancements in medical technology
  • 4.2.2. Restraints and Challenges
    • 4.2.2.1. Side effect
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers (Moderate)
  • 4.3.2. Threats of New Entrants: (Low)
  • 4.3.3. Bargaining Power of Buyers (Moderate)
  • 4.3.4. Threat of Substitute (Moderate)
  • 4.3.5. Rivalry among existing firms (High)
• 4.4. PESTLE Analysis
• 4.5. Neurothrombectomy Devices Industry trends
• 4.6. Value Chain Analysis
• 4.7. COVID-19 Impact Analysis

5. Global Neurothrombectomy Devices Market, by Product

• 5.1. Key Findings
• 5.2. Introduction
  • 5.2.1. Global Neurothrombectomy Devices, by Product, 2019-2032 (USD Million)
• 5.3. Clot Retrievers
  • 5.3.1. Global Neurothrombectomy Devices Market, by Clot Retrievers, by Region, 2019-2032 (USD Million)
• 5.4. Aspiration/Suction Devices
  • 5.4.1. Global Neurothrombectomy Devices Market, by Aspiration/Suction Devices, by Region, 2019-2032 (USD Million)
• 5.5. Vascular Snares
  • 5.5.1. Global Neurothrombectomy Devices Market, by Vascular Snares, by Region, 2019-2032 (USD Million)

6. Global Neurothrombectomy Devices Market, by End-Use

• 6.1. Key Findings
• 6.2. Introduction
  • 6.2.1. Global Neurothrombectomy Devices Market, by End-Use, 2019-2032 (USD Million)
• 6.3. Hospitals
  • 6.3.1. Global Neurothrombectomy Devices Market, by Hospitals, by Region, 2019-2032 (USD Million)
• 6.4. Emergency Clinics
  • 6.4.1. Global Neurothrombectomy Devices Market, by Emergency Clinics, by Region, 2019-2032 (USD Million)
• 6.5. Ambulatory Surgical Centers
  • 6.5.1. Global Neurothrombectomy Devices Market, by Ambulatory Surgical Centers, by Region, 2019-2032 (USD Million)

7. Global Neurothrombectomy Devices Market, by Geography

• 7.1. Key findings
• 7.2. Introduction
  • 7.2.1. Neurothrombectomy Devices Market Assessment, By Geography, 2019-2032 (USD Million)
• 7.3. Neurothrombectomy Devices Market - North America
  • 7.3.1. North America: Neurothrombectomy Devices Market, by End-Use, 2019-2032 (USD Million)
  • 7.3.2. North America: Neurothrombectomy Devices Market, by Product, 2019-2032 (USD Million)
  • 7.3.3. Neurothrombectomy Devices Market - U.S.
    • 7.3.3.1. U.S.: Neurothrombectomy Devices Market, by End-Use, 2019-2032 (USD Million)
    • 7.3.3.2. U.S.: Neurothrombectomy Devices Market, by Product, 2019-2032 (USD Million)
  • 7.3.4. Neurothrombectomy Devices Market - Canada
    • 7.3.4.1. Canada: Neurothrombectomy Devices Market, by End-Use, 2019-2032 (USD Million)
    • 7.3.4.2. Canada: Neurothrombectomy Devices Market, by Product, 2019-2032 (USD Million)
• 7.4. Neurothrombectomy Devices Market - Europe
  • 7.4.1. Europe: Neurothrombectomy Devices Market, by End-Use, 2019-2032 (USD Million)
  • 7.4.2. Europe: Neurothrombectomy Devices Market, by Product, 2019-2032 (USD Million)
  • 7.4.3. Neurothrombectomy Devices Market - UK
    • 7.4.3.1. UK: Neurothrombectomy Devices Market, by End-Use, 2019-2032 (USD Million)
    • 7.4.3.2. UK: Neurothrombectomy Devices Market, by Product, 2019-2032 (USD Million)
  • 7.4.4. Neurothrombectomy Devices Market - France
    • 7.4.4.1. France: Neurothrombectomy Devices Market, by End-Use, 2019-2032 (USD Million)
    • 7.4.4.2. France: Neurothrombectomy Devices Market, by Product, 2019-2032 (USD Million)
  • 7.4.5. Neurothrombectomy Devices Market - Germany
    • 7.4.5.1. Germany: Neurothrombectomy Devices Market, by End-Use, 2019-2032 (USD Million)
    • 7.4.5.2. Germany: Neurothrombectomy Devices Market, by Product, 2019-2032 (USD Million)
  • 7.4.6. Neurothrombectomy Devices Market - Italy
    • 7.4.6.1. Italy: Neurothrombectomy Devices Market, by End-Use, 2019-2032 (USD Million)
    • 7.4.6.2. Italy: Neurothrombectomy Devices Market, by Product, 2019-2032 (USD Million)
  • 7.4.7. Neurothrombectomy Devices Market - Spain
    • 7.4.7.1. Spain: Neurothrombectomy Devices Market, by End-Use, 2019-2032 (USD Million)
    • 7.4.7.2. Spain: Neurothrombectomy Devices Market, by Product, 2019-2032 (USD Million)
  • 7.4.8. Neurothrombectomy Devices Market - Netherlands
    • 7.4.8.1. Netherlands: Neurothrombectomy Devices Market, by End-Use, 2019-2032 (USD Million)
    • 7.4.8.2. Netherlands: Neurothrombectomy Devices Market, by Product, 2019-2032 (USD Million)
  • 7.4.9. Neurothrombectomy Devices Market - Russia
    • 7.4.9.1. Russia: Neurothrombectomy Devices Market, by End-Use, 2019-2032 (USD Million)
    • 7.4.9.2. Russia: Neurothrombectomy Devices Market, by Product, 2019-2032 (USD Million)
• 7.5. Neurothrombectomy Devices Market - Asia Pacific
  • 7.5.1. Asia Pacific: Neurothrombectomy Devices Market, by End-Use, 2019-2032 (USD Million)
  • 7.5.2. Asia Pacific: Neurothrombectomy Devices Market, by Product, 2019-2032 (USD Million)
  • 7.5.3. Neurothrombectomy Devices Market - China
    • 7.5.3.1. China: Neurothrombectomy Devices Market, by End-Use, 2019-2032 (USD Million)
    • 7.5.3.2. China: Neurothrombectomy Devices Market, by Product, 2019-2032 (USD Million)
  • 7.5.4. Neurothrombectomy Devices Market - India
    • 7.5.4.1. India: Neurothrombectomy Devices Market, by End-Use, 2019-2032 (USD Million)
    • 7.5.4.2. India: Neurothrombectomy Devices Market, by Product, 2019-2032 (USD Million)
  • 7.5.5. Neurothrombectomy Devices Market - Malaysia
    • 7.5.5.1. Malaysia: Neurothrombectomy Devices Market, by End-Use, 2019-2032 (USD Million)
    • 7.5.5.2. Malaysia: Neurothrombectomy Devices Market, by Product, 2019-2032 (USD Million)
  • 7.5.6. Neurothrombectomy Devices Market - Japan
    • 7.5.6.1. Japan: Neurothrombectomy Devices Market, by End-Use, 2019-2032 (USD Million)
    • 7.5.6.2. Japan: Neurothrombectomy Devices Market, by Product, 2019-2032 (USD Million)
  • 7.5.7. Neurothrombectomy Devices Market - Indonesia
    • 7.5.7.1. Indonesia: Neurothrombectomy Devices Market, by End-Use, 2019-2032 (USD Million)
    • 7.5.7.2. Indonesia: Neurothrombectomy Devices Market, by Product, 2019-2032 (USD Million)
  • 7.5.8. Neurothrombectomy Devices Market - South Korea
    • 7.5.8.1. South Korea: Neurothrombectomy Devices Market, by End-Use, 2019-2032 (USD Million)
    • 7.5.8.2. South Korea: Neurothrombectomy Devices Market, by Product, 2019-2032 (USD Million)
• 7.6. Neurothrombectomy Devices Market - Middle East & Africa
  • 7.6.1. Middle East & Africa: Neurothrombectomy Devices Market, by End-Use, 2019-2032 (USD Million)
  • 7.6.2. Middle East & Africa: Neurothrombectomy Devices Market, by Product, 2019-2032 (USD Million)
  • 7.6.3. Neurothrombectomy Devices Market - Saudi Arabia
    • 7.6.3.1. Saudi Arabia: Neurothrombectomy Devices Market, by End-Use, 2019-2032 (USD Million)
    • 7.6.3.2. Saudi Arabia: Neurothrombectomy Devices Market, by Product, 2019-2032 (USD Million)
  • 7.6.4. Neurothrombectomy Devices Market - UAE
    • 7.6.4.1. UAE: Neurothrombectomy Devices Market, by End-Use, 2019-2032 (USD Million)
    • 7.6.4.2. UAE: Neurothrombectomy Devices Market, by Product, 2019-2032 (USD Million)
  • 7.6.5. Neurothrombectomy Devices Market - Israel
    • 7.6.5.1. Israel: Neurothrombectomy Devices Market, by End-Use, 2019-2032 (USD Million)
    • 7.6.5.2. Israel: Neurothrombectomy Devices Market, by Product, 2019-2032 (USD Million)
  • 7.6.6. Neurothrombectomy Devices Market - South Africa
    • 7.6.6.1. South Africa: Neurothrombectomy Devices Market, by End-Use, 2019-2032 (USD Million)
    • 7.6.6.2. South Africa: Neurothrombectomy Devices Market, by Product, 2019-2032 (USD Million)
• 7.7. Neurothrombectomy Devices Market - Latin America
  • 7.7.1. Latin America: Neurothrombectomy Devices Market, by End-Use, 2019-2032 (USD Million)
  • 7.7.2. Latin America: Neurothrombectomy Devices Market, by Product, 2019-2032 (USD Million)
  • 7.7.3. Neurothrombectomy Devices Market - Mexico
    • 7.7.3.1. Mexico: Neurothrombectomy Devices Market, by End-Use, 2019-2032 (USD Million)
    • 7.7.3.2. Mexico: Neurothrombectomy Devices Market, by Product, 2019-2032 (USD Million)
  • 7.7.4. Neurothrombectomy Devices Market - Brazil
    • 7.7.4.1. Brazil: Neurothrombectomy Devices Market, by End-Use, 2019-2032 (USD Million)
    • 7.7.4.2. Brazil: Neurothrombectomy Devices Market, by Product, 2019-2032 (USD Million)
  • 7.7.5. Neurothrombectomy Devices Market - Argentina
    • 7.7.5.1. Argentina: Neurothrombectomy Devices Market, by End-Use, 2019-2032 (USD Million)
    • 7.7.5.2. Argentina: Neurothrombectomy Devices Market, by Product, 2019-2032 (USD Million)

8. Competitive Landscape

• 8.1. Expansion and Acquisition Analysis
  • 8.1.1. Expansion
  • 8.1.2. Acquisitions
• 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

• 9.1. Medtronic
  • 9.1.1. Company Overview
  • 9.1.2. Financial Performance
  • 9.1.3. Product Benchmarking
  • 9.1.4. Recent Development
• 9.2. Stryker Corporation
  • 9.2.1. Company Overview
  • 9.2.2. Financial Performance
  • 9.2.3. Product Benchmarking
  • 9.2.4. Recent Development
• 9.3. Acandis GmbH
  • 9.3.1. Company Overview
  • 9.3.2. Financial Performance
  • 9.3.3. Product Benchmarking
  • 9.3.4. Recent Development
• 9.4. Phenox GmbH
  • 9.4.1. Company Overview
  • 9.4.2. Financial Performance
  • 9.4.3. Product Benchmarking
  • 9.4.4. Recent Development
• 9.5. Penumbra Inc
  • 9.5.1. Company Overview
  • 9.5.2. Financial Performance
  • 9.5.3. Product Benchmarking
  • 9.5.4. Recent Development
• 9.6. Vesalio
  • 9.6.1. Company Overview
  • 9.6.2. Financial Performance
  • 9.6.3. Product Benchmarking
  • 9.6.4. Recent Development